Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 6/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 6/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1930630 | 1.00 | NQO1 (0.47) | NQO1PARP10PRSS1PRSS2PRSS3 | |
| SCHEMBL14273167 | 0.85 | NQO1 (0.48) | NQO1PARP10PRSS1PRSS2PRSS3 | |
| SCHEMBL28531601 | 0.81 | NQO2 (0.61) | NQO1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8746692 | 0.81 | NQO2 (0.61) | NQO1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL29483462 | 0.81 | NQO2 (0.61) | NQO1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL21457764 | 0.80 | PARP10 (0.47) | PARP10NPC1PLK1GAAALDH1A1 | |
| SCHEMBL16413555 | 0.80 | NQO1 (0.47) | NQO1PARP10PRSS1PRSS2PRSS3 | |
| SCHEMBL16413553 | 0.80 | NQO1 (0.47) | NQO1PARP10PRSS1PRSS2PRSS3 | |
| SCHEMBL16413554 | 0.80 | NQO1 (0.47) | NQO1PARP10PRSS1PRSS2PRSS3 | |
| SCHEMBL27589047 | 0.77 | CYP2A6 (0.44) | PDE4APDE4BPDE4CPDE4DPLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110137064-A1 | METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS | MEMPILE INC. (US) | 2011-06-09 | — | — | US | disclosed |
| US-20090161516-A1 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MEMPILE INC. (US) | 2009-06-25 | — | — | US | disclosed |
| EP-1888511-A1 | A METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | Mempile Inc. (US) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006117791-A1 | A METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MEMPILE INC. (US) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137064-A1 | METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS | MMAB, TET3, KDM2B | NQO1 4379/4885PARP10 1249/4885PRSS1 4440/4885 |
| US-20090161516-A1 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MMAB, HMBS, KDM2B | NQO1 4140/4885PARP10 928/4885PRSS1 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.